Cours Immunoprecise Antibodies Ltd Toronto S.E.
Actions
TQY
CA87588T2020
Produits pharmaceutiques
CA 2024 * | 24,59 M 18,09 M 16,27 M | CA 2025 * | 29,82 M 21,94 M 19,74 M | Capitalisation | 41,11 M 30,24 M 27,21 M |
---|---|---|---|---|---|
Résultat net 2024 * | -12 M -8,83 M -7,94 M | Résultat net 2025 * | -9 M -6,62 M -5,96 M | VE / CA 2024 * | 1,67 x |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | 1,38 x |
PER 2024 * |
-3,27
x | PER 2025 * |
-4,43
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 86,41% |
Dernier transcript sur Immunoprecise Antibodies Ltd
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jennifer Bath
CEO | Chief Executive Officer | - | 21/02/18 |
Kristin Taylor
DFI | Director of Finance/CFO | - | 29/09/23 |
Ilse Roodink
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mitchell Levine
CHM | Chairman | - | - |
Chris Buyse
BRD | Director/Board Member | 59 | 05/09/23 |
Jennifer Bath
CEO | Chief Executive Officer | - | 21/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,26% | 89,46 Md | |
+2,76% | 40,74 Md | |
-9,06% | 33,03 Md | |
+55,32% | 24,68 Md | |
-16,61% | 15,12 Md | |
-9,14% | 12,81 Md | |
-12,11% | 11,79 Md | |
-43,61% | 11,64 Md | |
+7,79% | 8,9 Md |